Question 1

Why isn't FDA cybersecurity enough on its own?

Accepted Answer

FDA reviews the device. SOC 2 reviews the organization operating the cloud and processes around it. Hospital procurement teams ask for both, plus HIPAA and (for large IDNs) HITRUST. We build them on one shared control set so the work isn't duplicated.

Question 2

Type I or Type II - which do I need?

Accepted Answer

Type II. A Type I (point-in-time) report buys you no procurement credit at hospitals or large enterprise customers. Type II shows 3 to 12 months of operating evidence and is what InfoSec teams expect to see attached to your security questionnaire response.

Question 3

Which Trust Services Criteria should I include?

Accepted Answer

Security is mandatory. Most MedTech vendors also need Availability and Confidentiality. Add Privacy if you're handling PHI directly, and Processing Integrity if your device or SaaS produces clinical outputs. We size the scope to what your buyers actually require - over-scoping wastes 30-50% of the budget.

Question 4

Do you do the audit yourselves?

Accepted Answer

No - SOC 2 audits must be performed by an independent CPA firm. We handle readiness, control build, evidence collection, and audit coordination. We work with several CPA firms we trust, or we can work with one you bring.

Question 5

How does this map to FDA, HIPAA, HITRUST, and GDPR?

Accepted Answer

Roughly 70% of SOC 2 controls also satisfy FDA cybersecurity SPDF expectations, the HIPAA Security Rule, HITRUST CSF (e1 and i1 levels), and GDPR Article 32. We deliver a written crosswalk in week 1 so you can see exactly which controls produce evidence for which framework.

Question 6

How long until we have a Type II report in hand?

Accepted Answer

6-9 months for a 3-month observation window, 9-12 months for a 6-month window. Most hospital procurement teams accept either. The longest lead time is the observation period itself, which is why we recommend starting SOC 2 6-9 months before your FDA submission lands.

Question 7

What's a SOC 2 bridge letter and when do we need one?

Accepted Answer

A bridge letter (also called a 'gap letter') is a short attestation from management - sometimes counter-signed by the auditor - that covers the period between the end of your most recent SOC 2 report and a customer's current procurement review. Hospital InfoSec teams typically require a bridge letter once your report is more than 90 days old. We provide a bridge-letter template, pre-fill the system description and TSC scope, and refresh it quarterly so your sales team can hand it out without going back to the auditor each time. The bridge letter does not extend the audit opinion - it confirms that no material control changes occurred in the gap period.

Question 8

How do we handle SOC 2 for our cloud and AI sub-service organizations?

Accepted Answer

Every sub-service organization (AWS, Azure, GCP, OpenAI, Anthropic enterprise, observability, payment processors) that supports your in-scope system has to be addressed in your SOC 2 report - either inclusively (you scope and audit them, which is rare) or carve-out (you exclude their controls from your scope and rely on their own SOC reports). We inventory your sub-service organizations during scoping, secure their current SOC 2 / ISO 27001 reports, document the carve-out methodology, and define the complementary user entity controls (CUECs) you must operate. This carve-out work is where many first-time SOC 2 reports get qualified - we handle it cleanly upfront.

Question 9

Should we use Vanta, Drata, or SecureFrame - or run SOC 2 without GRC tooling?

Accepted Answer

Either works. GRC tooling (Vanta, Drata, SecureFrame, Thoropass) automates 60-80% of evidence collection and is the right call for cloud-native teams with 10-100 engineers. The annual cost ($30k-$80k) is offset by the engineering time you save during evidence collection and the Type II observation period. For pre-Series-A teams with limited cash, a hardened SharePoint/Confluence + scheduled evidence-collection workflow is workable for the first cycle. We're tool-agnostic - we'll implement either path and have working integrations with all major GRC platforms. The decision is operational, not strategic.

Question 10

What causes a qualified SOC 2 opinion, and how do we avoid one?

Accepted Answer

Qualified opinions ('except for...') happen when the auditor identifies a material control deficiency or a scope limitation. The most common causes: missing evidence for the observation period (a control was 'designed but not operating'), inadequate carve-out documentation for sub-service organizations, change-management gaps where production deploys bypassed approval, access-review backlogs, and incident-response controls that weren't tested. Our readiness work and quarterly evidence reviews specifically target these patterns. A qualified opinion isn't fatal - many large vendors have one - but hospital procurement and large enterprise customers will read it, ask questions, and slow your sales cycle.

SOC 2 Type II for MedTech. Procurement-ready, not paper-only.

Why MedTech SOC 2 projects stall

Type I won't close the deal

Wrong Trust Services Criteria

Evidence collected in a panic

Controls we build and operate

Access & identity

Engineering & SDLC

Operations & monitoring

Vendor & risk

How the SOC 2 Type II program runs

1. Scoping & gap assessment

2. Control build & policy stack

3. Observation period

4. Audit & report

Reviewer-ready deliverables in one engagement

Related Premarket services

Full-Service FDA Premarket Cybersecurity

FDA Deficiency Response

FDA-Compliant SBOM Services

SOC 2 Type II for MedTech FAQs

Backed by MedTech leaders.

SOC 2 Type II for MedTech - scoped, fixed-fee, FDA-ready.